Modeling familial cancer with induced pluripotent stem cells.
Modeling familial cancer with induced pluripotent stem cells.
复制标题
DOI:
10.1016/j.cell.2015.02.045
复制
发表时间:
2015-04-09
期刊:
影响因子:
64.5
通讯作者:
Lemischka IR
中科院分区:
文献类型:
--
作者:
Lee DF;Su J;Kim HS;Chang B;Papatsenko D;Zhao R;Yuan Y;Gingold J;Xia W;Darr H;Mirzayans R;Hung MC;Schaniel C;Lemischka IR
In vitro modeling of human disease has recently become feasible with induced pluripotent stem cell (iPSC) technology. Here, we established patient-derived iPSCs from a Li-Fraumeni Syndrome (LFS) family and investigated the role of mutant p53 in the development of osteosarcoma (OS). LFS iPSC-derived osteoblasts (OBs) recapitulated OS features including defective osteoblastic differentiation as well as tumorigenic ability. Systematic analyses revealed that the expression of genes enriched in LFS-derived OBs strongly correlated with decreased time to tumor recurrence and poor patient survival. Furthermore, LFS OBs exhibited impaired upregulation of the imprinted gene H19 during osteogenesis. Restoration of H19 expression in LFS OBs facilitated osteoblastic differentiation and repressed tumorigenic potential. By integrating human imprinted gene network (IGN) into functional genomic analyses, we found that H19 mediates suppression of LFS-associated OS through the IGN component DECORIN (DCN). In summary, these findings demonstrate the feasibility of studying inherited human cancer syndromes with iPSCs.
登录
查看更多内容
影响因子:
15.8
作者:
Barberi T;Willis LM;Socci ND;Studer L
通讯作者:
Studer L
影响因子:
64.8
作者:
HAO, Y;CRENSHAW, T;TYCKO, B
通讯作者:
TYCKO, B
影响因子:
56.9
作者:
MALKIN, D;LI, FP;FRIEND, SH
通讯作者:
FRIEND, SH
影响因子:
64.5
作者:
Takahashi, Kazutoshi;Yamanaka, Shinya
通讯作者:
Yamanaka, Shinya
影响因子:
5.6
作者:
Mirzayans, Razmik;Andrais, Bonnie;Murray, David
通讯作者:
Murray, David